Dengue type 4 virus mutants containing deletions in the 3′ noncoding region of the RNA genome: Analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3930-3937

  Men, Ruhe ^a   Bray, Michael ^a   Clark, Debbie ^a   Chanock, Robert M ^a   Lai, Ching Juh ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFORMATIONAL TRANSITION; DELETION MUTANT; DENGUE VIRUS; GENE DELETION; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RHESUS MONKEY; RNA SEQUENCE; RNA TRANSCRIPTION; VIRUS GENE; VIRUS INFECTIVITY; VIRUS MUTATION;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CELLS, CULTURED; DENGUE; DENGUE VIRUS; DNA, COMPLEMENTARY; GENE DELETION; GENOME, VIRAL; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MUTATION; RNA, VIRAL; VIREMIA;

EID: 0029893436     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ada, G. L., and S. G. Anderson. 1959. Yield of infective 'ribonucleic acid' from impure Murray Valley encephalitis, virus after different treatments. Nature (London) 183:799-800.
2. Bancroft, W. H., J. M. McCown, P. M. Lago, W. E. Brandt, and P. K. Rusell. 1979. Identification of dengue viruses from the Caribbean by plaque-reduction neutralization test: Dengue in the Caribbean. Pan Am. Health Organ. Sci. Publ. 375:173-178.
3. Bancroft, W. H., R. M. Scott, K. H. Eckels, C. H. Hoke, Jr., T. E. Simms, K. D. T. Jesrani, P. L. Summers, D. R. Dubois, D. Tsoulos, and P. K. Russell. 1984. Dengue virus type 2 vaccine: reaclogenicity and immunogenicity in soldiers, J. Infect. Dis. 149:1005-1010.
4. Bartholomeusz, A. I., and P. J. Wright. 1993. Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5. Arch. Virol. 128:111-121.
5. 4a.Bhamarapravali, N., S. Yoksan, T. Chayaniyayothin, S. Angsubphakorn, and A. Bunyaratvej. 1987. Immunization with a live attenuated dengue 2 virus candidate vaccine (16681-PDK53): clinical, immunolngical and biological responses in adult volunteers. Bull. W. H. O. 65:189-195.
6. Bray, M., R. Men, and C.-J. Lai. 1996. Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. J. Virol. 70:4162-4166.
7. Brinton, M. A., A. V. Fernandez, and J. H. Dispopto. 1986. The 3′-nucleotides of flavivirus genomic RNA form a conserved secondary structure. Virology 153:113-121.
8. Cahour, A., A. Pletnev, M. Vazeille-Falcoz, L. Rosen, and C.-J. Lai. 1995. Growth-restricted dengue virus mutants containing deletions in the 5′ noncoding region of the RNA genome. Virology 207:68-76.
9. Chambers, T. J., C. S. Hahn, R. Galler, and C. M. Rice. 1990. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44:649-688.
10. Eckels, K. H., M. Scott, W. H. Bancroft, J. Brown, D. R. Dubois, P. L. Summers, P. K. Russell, and S. B. Halstead. 1984. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. Am. J. Trop. Med. Hyg. 33:684-689.
11. Edelman, R., C. O. Tacket, S. S. Wasserman, D. W. Vaughn, D. W. Vaushn, K. H. Eckels, D. R. Dubois, P. L. Summers, and C. H. Hoke. 1994. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cells culture is attenuated and immunogenic for humans. J. Infect. Dis. 178:1448-1455.
12. Grun, J. B., and M. A. Brinton. 1987. Dissociation of NS5 from cell fractions containing West Nile virus-specific polymerase activity. J. Virol. 61:3641-3644.
13. Hahn, C. S., Y. S. Hahn, C. M. Rice, E. Lee, L. Dalgarno, E. G. Strauss, and J. H. Strauss. 1987. Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences. J. Mol. Biol. 198:33-41.
14. Harrison, V. R., K. H. Eckels, J. W. Sagartz, and P. K. Russell. 1977 Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect. Immun. 18:151-156.
15. Hoke, C. H., Jr., F. J. Malinoski, K. H. Eckels, R. M. Scott, D. R. Dubois, P. L. Summers, T. Simms, J. Burrous, S. E. Hasty, and W. H. Bancroft. 1990. Preparation of an attenuated dengue 4 (341 750 CARIB) virus vaccine. II. Safety and immunogenicity in humans. Am. J. Trop. Med. Hyg. 43:219-226.
16. Hotta, S. 1952. Experimental studies an dengue. I. Isolation, identification and modification of the virus. J. Infect. Dis. 90:1-9.
17. Innis, B. L., K. H. Eckels, E. Kraiselburd, D. R. Dubois. G. F. Meadors, D. J. Gubler, D. S. Burke, and W. H. Bancroft. 1988. Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. J. Infect. Dis. 158:876-880.
18. Jacobson, S. J., D. A. M. Konings, and P. Sarnow. 1993. Biochemical and genetic evidence for a pseudoknot structure at the 3′ terminus of the poliovirus RNA genome and its role in viral RNA amplification. J. Virol. 67:2961-2971.
19. Kuhn, R. J., D. E. Griffin, H. Zhang, H. G. M. Niesters, and J. H. Strauss. 1992. Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA. J. Virol. 66:7121-7127.
20. Kuhn, R. J., H. Zhang, and J. H. Strauss. 1990. Mutagenesis of the 3′ untranslated region of Sindbis virus RNA. J. Virol. 64:1465-1476.
21. Lai, C.-J., V. Zhang, R. Men, M. Bray, and R. M. Chanock. 1990. Immunization of monkeys with baculovirus recombinant-expressed dengue envelope and NS1 glycoproteins induces partial resistance to challenge with homotypic dengue virus, p. 119-124. In F. Brown, R. M. Chanock, H. S. Ginsaherg, and R. Lerner (ed.), Vaccines 90: modern approaches to new vaccines, including prevention of AIDS. Cold Spring Harbor Laboratory, Cold Spring Harbor. N.Y.
22. Lai, C.-J., B. Zhan, H. Hori, and M. Bray. 1991. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc. Natl. Acad. Sci. USA 88:5139-5143.
23. Marchette, N. J., D. R. Dubois, L. K. Larsen, P. L. Summers, E. G. Kraiselburd, D. J. Gubler, and K. H. Eckels. 1990. Preparation of an attenuated dengue 4 (341750 CARIB) virus vaccine. I. Pre-clinical studies. Am. J. Trop. Med.Hyg. 43:212-218.
24. Monozova, O. V., N. A. Belyavskaya, E. F. Zaychiknv, E. A. Kvelkova, A. A. Mustaev, and A. G. Pletnev. 1991. Identification of RNA replicase subunits responsible for initiation of RNA synthesis of tick-borne encephalitis virus by affinity labelling. Biomed. Sci. 2:183-186.
25. Pethel, M., B. Falgout, and C.-J. Lai. 1992. Mutational analysis of the octapeptide sequence motif at the NS1-NS2A cleavage junction of dengue type 4 virus. J. Virol. 66:7225-7231.
26. Pletnev, A. G., M. Bray, J. Huggins, and C.-J. Lai. 1992. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc. Natl. Acad. Sci. USA 89:10532-10536.
27. Rice, C. M., E. M. Lenches, S. R. Eddy, S. J. Shin, R. L. Sheets, and J. H. Strauss. 1985. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726-733.
28. Rosen, L. 1958. Experimental infection of New World monkeys with dengue and yellow fever viruses. Am. J. Trop. Med. Hyg. 7:406-410.
29. Sabin, A. B. 1952. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1:30-50.
30. Sabin, A. B. 1955. Recent advances in our knowledge of dengue and sandfly fever. Am. J. Trop. Med. Hyg. 4:198-207.
31. Takegam, T., M.Washizu, and K. Yasui. 1986. Nucleotide sequence at the 3′ end of Japanese encephalitis virus genomic RNA. Virology 152:483-486.
32. Wengler, G., and E. Castle. 1986. Analysis of structural properties which possibly are characteristic for the 3′-terminal sequence of the genome RNA of flaviviruses. J. Gen. Virol. 67:1183-1188.
33. Zhao, B., E. Mackow, A. Buckler-White, L. Markoff, R. M. Chanock, C.-J. Lai, and Y. Makino. 1986. Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. Virology 155:77-88.